Open Targets Blog
  • Home
  • Release Notes
  • Genetics release
  • Science
  • Q&A
  • Platform
Subscribe

CRISPR/Cas9

A collection of 7 posts

Cancer

An Open Targets Away Day with The Institute of Cancer Research

Open Targets meets colleagues at the Institute of Cancer Research in London: potential collaboration ahead of us.

Ian Dunham, David Hulcoop
Open Targets Platform

On diseases and phenotypes, and how we learnt to stop worrying and ignore the distinction

One of the questions that Open Targets Platform users ask is why we don't distinguish diseases from phenotypes. Ian Dunham tells us more in this blog post.

Ian Dunham
A-Z

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. This time we have a double bill: F and G.

Denise Carvalho-Silva
Q&A

Using CRISPR priority score to identify targets in cancer drug discovery

Open Targets Q&A on the first set of CRISPR screen results in cancer for target identification and prioritisation in drug discovery.

Fiona Behan, Denise Carvalho-Silva
release notes

Open Targets Platform: release 19.04 is out

We have a new release of the Open Targets Platform: CRISPR-Cas9 data and target safety information are some of the highlights in release 19.04.

Denise Carvalho-Silva
A-Z

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. Third in the series is C.

Denise Carvalho-Silva
Open Targets

How CRISPR will guide the way to better cancer therapies

Fiona Behan tells us why she works in cancer research with Open Targets and how CRISPR/Cas9 has revolutionised the fight against cancer.

Fiona Behan
Open Targets Blog © 2021
Latest Posts Twitter Ghost
Open Targets Blog

Subscribe to Open Targets Blog

Stay up to date! Get all the latest & greatest posts delivered straight to your inbox